Nanjing Shengderui Pharmaceutical Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Nanjing Shengderui Pharmaceutical General Information
Description
Developer of innovative diabetes therapeutics designed to treat metabolic diseases through glucose kinase science and pancreatic islet research. The company develops glucose kinase activators and islet-focused metabolic drug candidates, enabling healthcare providers to offer more effective treatment options for patients with type 2 diabetes and related metabolic disorders.
Contact Information
Website
www.ascendrare.com(Operating Subsidiary)
Corporate Office
- 2nd Floor, Building D-3
- Number 73 Tanmi Road, Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Corporate Office
- 2nd Floor, Building D-3
- Number 73 Tanmi Road, Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Nanjing Shengderui Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nanjing Shengderui Pharmaceutical Signals
Nanjing Shengderui Pharmaceutical FAQs
-
When was Nanjing Shengderui Pharmaceutical founded?
Nanjing Shengderui Pharmaceutical was founded in 2018.
-
Where is Nanjing Shengderui Pharmaceutical headquartered?
Nanjing Shengderui Pharmaceutical is headquartered in Nanjing, China.
-
What is the size of Nanjing Shengderui Pharmaceutical?
Nanjing Shengderui Pharmaceutical has 5 total employees.
-
What industry is Nanjing Shengderui Pharmaceutical in?
Nanjing Shengderui Pharmaceutical’s primary industry is Drug Discovery.
-
Is Nanjing Shengderui Pharmaceutical a private or public company?
Nanjing Shengderui Pharmaceutical is a Private company.
-
What is the current valuation of Nanjing Shengderui Pharmaceutical?
The current valuation of Nanjing Shengderui Pharmaceutical is .
-
What is Nanjing Shengderui Pharmaceutical’s current revenue?
The current revenue for Nanjing Shengderui Pharmaceutical is .
-
When was Nanjing Shengderui Pharmaceutical acquired?
Nanjing Shengderui Pharmaceutical was acquired on 02-Dec-2022.
-
Who acquired Nanjing Shengderui Pharmaceutical?
Nanjing Shengderui Pharmaceutical was acquired by Hua Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process